
Full text loading...
Patients, scientists, regulators, and the public may each view early stage stem cell-based clinical trials from varying perspectives and interests. In this talk I explain these various points of view, their differences, and their importance to the ethics of stem cell-based clinical trials. Based on this multiple perspectives analysis, I conclude with some ethical recommendations for the conduct of early stage human trials necessary to advance stem cell science.